A CAREER IN THE PHARMACEUTICAL INDUSTRY: PRACTICE YOUR PROFESSION. Michael Dunne, MD NIH/NIAID Career Symposia June 5, 2015

Size: px
Start display at page:

Download "A CAREER IN THE PHARMACEUTICAL INDUSTRY: PRACTICE YOUR PROFESSION. Michael Dunne, MD NIH/NIAID Career Symposia June 5, 2015"

Transcription

1 A CAREER IN THE PHARMACEUTICAL INDUSTRY: PRACTICE YOUR PROFESSION Michael Dunne, MD NIH/NIAID Career Symposia June 5, 2015

2 Change is afoot.. Now what do I do? Government funded research is under pressure >90% of clinical practices will be owned by a hospital corporation Everyone will work for someone in the future In the Pharmaceutical Industry: High-throughput screening is not as productive as hoped More consolidation is coming and more Spin outs More research being done in smaller organizations Big data will change everything

3 The Clinician in Industry Overarching mission of clinicians in industry The structure of research in a business environment Where does the clinician fit in? Practical things you need to know Questions you need to wrestle with The Good and the Bad

4 The Role of the Clinician in Industry Bring clinical relevance to research Champion ideas that are good for patients Prioritize good and relevant ideas to gain funding Guide the science Ensure patient safety Deliver data that meets regulatory requirements Enable the integration of new drugs into clinical practice

5 Industry: The Moving Parts Research Funding Generic Industry Deliverables Small-cap Pharma Research Based Biotechnology Clinical Development Program(s) Mid-cap Pharma Contract Research Organizations Privately Held New Drug Approvals Large Pharma Public Markets Director Senior Director Executive Director Vice President Senior Vice President Chief Medical Officer Chief Science Officer Interdisciplinary Interactions Public Health Interactions Collaborations and Publications Chief Executive Officer

6 Prioritizing then funding ideas varies with the size of the organization Concept Small-cap Pharma Mid-cap Pharma Large Pharma Private Equity Venture Funds Stock Market IPO/secondary Reinvestment of Profits Debt Financing

7

8

9 FY 2012 President s Budget Request NIH Total Program Level $31,987 Million Research Centers 9% Other Research 6% Research Training 2% Research Project Grants 53% R&D Contracts 11% Intramural Research 11% All Other 3% Res. Mgmt. & Support 5%

10

11 Clinicians in Industry Clinical Development Phase 1 Phase 2 Phase 3 FDA Approval Director Senior Director Executive Director Vice President Medical Affairs Phase 3b Phase 4 Investigator Initiated Studies Medical Information Senior Vice President Chief Medical/Science/Executive Officer Typical Experience at Entry Fellowship 1-2 year private practice >5 years private Practice

12 Things I ve Wanted to Know About Industry What do I actually do all day? What kind of projects will I work on? Can I see patients while working in Industry? With all the mergers how long will I keep my job? Will I give up my scientific independence? What is the role of the commercial organization? Can I achieve a work-life balance?

13 Hours at Work Kane L, Peckham C. Medscape Physician Compensation Report 2014

14 Satisfied with Medicine as a Career Kane L, Peckham C. Medscape Physician Compensation Report 2014

15 Relative Compensation Kane L, Peckham C. Medscape Physician Compensation Report 2014

16 Relative Compensation Medical Director, Pharmaceutical Industry Kane L, Peckham C. Medscape Physician Compensation Report 2014; Salary.com; Glassdor.com

17 The Good and the Bad The Good Opportunity for clinical research Broad view of Medicine Collaboration with good scientists Good work-life balance Opportunity for advancement The Bad Narrow focus on one product Bureaucracy Challenging environment for influence Rewards are long(er) term Subject to change in corporate priorities

18 Questions you need to answer for yourself Would I enjoy research, clinical or bench, all day, every day? Are you willing to work in a team environment? Will you feel good about your contribution to medicine in an industry setting? Are you comfortable defending clinical perspectives in an environment of individuals who are not clinically trained?...and will challenge you? Can you accept criticism of your data by a skeptical audience? Relman AS. The new medical-industrial complex. N Engl J Med 1980; 303: Heinemann L, Hompesch M. Journal of Diabetes Science and Technology Volume 2, Issue 4, July Shuchman M. Commercializing clinical trials--risk and benefits of the CRO. N Engl J Med. 2007;357(14): Stossel TP. Regulating academic-industrial research relationships--solving the problems or stifling progress? N Engl J Med. 2005;353(10): Kesselheim AS, Robertson CT, Myers JA, et al. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012; 367: Rothman KJ. Conflict of interest: the new McCarthyism in science. JAMA 1993; 269:

19 Advice for long run Follow the Drug Miracles in a bottle do not grow on trees Be where the decisions are made They need you to be part of the decisions Socialize your opinions It s a huge team effort and face-time matters Patients (always first) Products People (who staff the projects) Process

20 A CAREER IN THE PHARMACEUTICAL INDUSTRY: PRACTICE YOUR PROFESSION Michael Dunne NIH/NIAID Career Symposia June 5, 2015

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial

More information

Big Data for Patients (BD4P) Program Overview

Big Data for Patients (BD4P) Program Overview Big Data for Patients (BD4P) Program Overview [Updated August 5, 2015] Proposal: Big Data for Patients (BD4P) Training Program Page 1 Background The new and emerging field of data science ( Big Data )

More information

the solution. I think too much of the health care issues we re faced with as opposed to the problem.

the solution. I think too much of the health care issues we re faced with as opposed to the problem. Introduction: Hi I m Sherrie Bossing and I manage Lilly s corporate brand and volunteer strategy worldwide. I m joined today with Dr. Jack Harris who is the Vice President responsible for US Medical Division,

More information

Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry

Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a

More information

HOT TOPICS IN IN HEALTH CARE REFORM

HOT TOPICS IN IN HEALTH CARE REFORM By Felicia Fuller Publications Manager, DAC Patient Recruitment Services The Patient Protection and Affordable Care Act (ACA), colloquially known as Obamacare, is in full effect and its impact is palpable

More information

ROI through Quality Improvement: Davies Winner Lessons from the Field Steve Robertson Dale Glenn, MD

ROI through Quality Improvement: Davies Winner Lessons from the Field Steve Robertson Dale Glenn, MD ROI through Quality Improvement: Davies Winner Lessons from the Field Steve Robertson Dale Glenn, MD DISCLAIMER: The views and opinions expressed in this presentation are those of the author and do not

More information

Pharmaceutical Industry: Research and Development

Pharmaceutical Industry: Research and Development Pharmaceutical Industry: Research and Development Background Pharmacists in industry are employed in a variety of positions. Although practice titles, descriptions, and prerequisites differ by company,

More information

Careers in Medical and Scientific Writing

Careers in Medical and Scientific Writing Careers in Medical and Scientific Writing Laura McCormick, PhD Vice President Associate Practice Leader Tamara Fink, PhD Associate Scientific Director ProEd Communications, Inc Beachwood, Ohio Agenda Introduction

More information

Appendix C: Glossary of Terms Policies on Innovation Management and Conflicts of Interest

Appendix C: Glossary of Terms Policies on Innovation Management and Conflicts of Interest Appendix C: Glossary of Terms Policies on Innovation Management and Conflicts of Interest ACCME means Accreditation Council for Continuing Medical Education. Cleveland Clinic main campus means Main Campus,

More information

SPHERIX INCORPORATED (Exact name of registrant as specified in its charter)

SPHERIX INCORPORATED (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q 2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements

More information

Pharmaceutical Sciences

Pharmaceutical Sciences Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

The agency perspective: What we do and how we do it

The agency perspective: What we do and how we do it The agency perspective: What we do and how we do it Tim Ryder and Olga Dai 15 July 2011 Who are we? Tim Ryder Scientific Team Leader, Darwin HC MA in Biochemistry; DPhil in Physiology 10 years of experience

More information

Clinical Research Market in Poland. Barbara Kozierkiewicz

Clinical Research Market in Poland. Barbara Kozierkiewicz Clinical Research Market in Poland Barbara Kozierkiewicz Agenda Why pharma R&D? Clinical trials introduction Clinical trials market in Poland Opportunities and challenges Global vs. local clinical research

More information

Learn from the Pharmaceutical Companies: Develop Sales Campaigns that Deliver Top Results!

Learn from the Pharmaceutical Companies: Develop Sales Campaigns that Deliver Top Results! AN OVERVIEW Learn from the Pharmaceutical Companies: Develop Sales Campaigns that Deliver Top Results! Michael Ferris Principal Simione Healthcare Consultants mferris@simione.com GOALS: Demonstrate how

More information

ACCP. Update: The Clinical Pharmacist as Principal Investigator

ACCP. Update: The Clinical Pharmacist as Principal Investigator ACCP Update: The Clinical Pharmacist as Principal Investigator American College of Clinical Pharmacy Michael E. Burton, Pharm.D, Mark A. Munger, Pharm.D., FCCP, FACC, Edward M. Bednarczyk, Pharm.D., FCCP,

More information

A Primer: Solving the Unique Problems of Orphan Drug Communications Programs

A Primer: Solving the Unique Problems of Orphan Drug Communications Programs A Primer: Solving the Unique Problems of Orphan Drug Communications Programs Introduction When communicating about orphan diseases and development of pharmaceuticals, it is essential to recognize the special

More information

Osteoporosis Drug Development Moving Forward Public Workshop

Osteoporosis Drug Development Moving Forward Public Workshop Osteoporosis Drug Development Moving Forward Public Workshop November 4, 2015 Discussion Panel Members and Speakers Robert Adler, MD Chief, Endocrinology and Metabolism McGuire Veterans Affairs Medical

More information

Gauging the Biosimilar Effect: will the market boom or bust?

Gauging the Biosimilar Effect: will the market boom or bust? Brochure More information from http://www.researchandmarkets.com/reports/2041781/ Gauging the Biosimilar Effect: will the market boom or bust? Description: It was supposed to be the epoch of biosimilars,

More information

Post-Doctoral Pharmaceutical Industry Fellowships. Two-Year Clinical Development Program Two-Year Clinical Safety Program

Post-Doctoral Pharmaceutical Industry Fellowships. Two-Year Clinical Development Program Two-Year Clinical Safety Program Post-Doctoral Pharmaceutical Industry Fellowships Two-Year Clinical Development Program Two-Year Clinical Safety Program Today, we innovate by creating new medicines, as well as new methods of drug discovery

More information

Q&A Intellectual Property Policy

Q&A Intellectual Property Policy Q&A Intellectual Property Policy Table of Contents Q: Why have an Intellectual Property Policy?... 3 Q: Does the IP Policy apply to me?... 3 Q: I am primarily affiliated with another institution and am

More information

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor The Biotech Business Life Cycle and The Lawyer s Role as Counselor and Advisor ASU February 15, 2010 1 BIOTECH BUSINESS CYCLE AN INTERDISCIPLINARY APPROACH TO LEGAL REPRESENTATION Intellectual Property

More information

FDA STAFF MANUAL GUIDES, VOLUME I ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES

FDA STAFF MANUAL GUIDES, VOLUME I ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES SMG 1117.33 FDA STAFF MANUAL GUIDES, VOLUME I ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES DIVISION OF POLICY, PROGRAMS, AND EXECUTIVE RESOURCES

More information

Conscientious Collaboration: A Proactive Approach to Ensuring Ethical Interactions with Healthcare Professionals

Conscientious Collaboration: A Proactive Approach to Ensuring Ethical Interactions with Healthcare Professionals Conscientious Collaboration: A Proactive Approach to Ensuring Ethical Interactions with Healthcare Professionals Executive Summary Medical device and pharmaceutical manufacturers depend on collaboration

More information

Academic Health Center Six-Year Strategic Plan October 20, 2000

Academic Health Center Six-Year Strategic Plan October 20, 2000 Goal 1: Create and Prepare the New Health Professionals for Minnesota Strategic Objectives 1.0 Develop and implement interdisciplinary health professional education opportunities that: Emphasize the core

More information

Some Biomedical Informatics Programs at NIBIB and NIH

Some Biomedical Informatics Programs at NIBIB and NIH Some Biomedical Informatics Programs at NIBIB and NIH BIBM 2009 November 3, 2009 Zohara Cohen, PhD of Biomedical Imaging & Bioengineering NIH, DHHS Training Grants and Fellowships: Career Development Awards

More information

Position Specification

Position Specification (UK) Position Specification Lexington, Kentucky POSITION ORGANIZATION LOCATION (UK) Lexington, KY REPORTING RELATIONSHIPS Executive Vice President for Health Affairs Provost POSITION DESCRIPTION The Center

More information

EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS. Table of Contents

EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS. Table of Contents EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS Table of Contents EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL

More information

PA s and Research. Possibilities, Opportunities and Challenges. Charles DiMaggio, PhD, MPH, PA-C

PA s and Research. Possibilities, Opportunities and Challenges. Charles DiMaggio, PhD, MPH, PA-C PA s and Research Possibilities, Opportunities and Challenges Charles DiMaggio, PhD, MPH, PA-C Departments of Anesthesiology and Epidemiology College of Physicians and Surgeons Columbia University New

More information

The Options Available for Entering Dental Practice. Immediate income needs. Financial resources available. Current debt status

The Options Available for Entering Dental Practice. Immediate income needs. Financial resources available. Current debt status Chapter 2: The Options Available for Entering Dental Practice Following the completion of dental training and the earning of a dental degree, dentists are faced with deciding how they will enter into dental

More information

Principles to Guide the Relationship between Graduate Medical Education, Industry, and Other Funding Sources

Principles to Guide the Relationship between Graduate Medical Education, Industry, and Other Funding Sources 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Principles to Guide the Relationship between Graduate Medical

More information

Medical Writing in Focus A Med Comms Agency Perspective. Mike Thompson Scientific Director, Complete Medical Group

Medical Writing in Focus A Med Comms Agency Perspective. Mike Thompson Scientific Director, Complete Medical Group Medical Writing in Focus A Med Comms Agency Perspective Mike Thompson Scientific Director, Complete Medical Group The next 15 minutes How I became a Medical Writer! Options for a medical writing career

More information

PROJECT MANAGEMENT AS A CAREER PATH FOR PHDS: PERSPECTIVE FROM BIOTECH AND NONPROFIT SECTORS

PROJECT MANAGEMENT AS A CAREER PATH FOR PHDS: PERSPECTIVE FROM BIOTECH AND NONPROFIT SECTORS PROJECT MANAGEMENT AS A CAREER PATH FOR PHDS: PERSPECTIVE FROM BIOTECH AND NONPROFIT SECTORS Sanya Fanous Whitaker Scientific Program Manager Foundation for the National Institutes of Health June 26, 2015

More information

Big Data to Knowledge (BD2K)

Big Data to Knowledge (BD2K) Big Data to Knowledge () potential funding agency synergies Jennie Larkin, PhD Office of the Associate Director of Data Science National Institutes of Health idash-pscanner meeting UCSD September 16, 2014

More information

First Fridays Webinar Series: Medical Education Group (MEG)

First Fridays Webinar Series: Medical Education Group (MEG) First Fridays Webinar Series: Medical Education Group (MEG) Webinar #1 - May 7 th, 2010 Series Goals (5) 1. To provide insights into how Pfizer s Medical Education Group (MEG) functions an operational

More information

A PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT

A PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT Accelovance 2275 Research Boulevard, Suite 700 Rockville, MD 20850, United States Phone: +1.240.238.4900 Fax: +1.240.238.4901 Internet: www.accelovance.com email: gsmith@accelovance.com Contact Person:

More information

Clinically Integrated Networks and Accountable Care Organizations

Clinically Integrated Networks and Accountable Care Organizations Clinically Integrated Networks and Accountable Care Organizations 1 Do Nothing 2 Become Someone s Employee 3 Join a Network Provider The wake up call is for POPULATION health management managing clinical

More information

LEADERSHIP DEVELOPMENT PROGRAM OVERVIEW

LEADERSHIP DEVELOPMENT PROGRAM OVERVIEW LEADERSHIP DEVELOPMENT PROGRAM OVERVIEW Assuring a dedicated and experienced set of members to assume positions of leadership in the Society has been an ongoing goal of the ASNC Board of Directors. To

More information

Concepts in Pharmaceutical Development Project Management. Christopher D. Breder, MD PhD. Clinical Team Leader, Anesthetic Drugs

Concepts in Pharmaceutical Development Project Management. Christopher D. Breder, MD PhD. Clinical Team Leader, Anesthetic Drugs Concepts in Pharmaceutical Development Project Management Christopher D. Breder, MD PhD Clinical Team Leader, Anesthetic Drugs Division of Anesthesia, Analgesia, and Addiction Products Disclaimer The views

More information

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015 BioWales 2015 Pharmaceutical Supply Chain Showcase 04 March 2015 SIMBEC RESEARCH 40 YEARS EXPERIENCE IN EARLY STAGE CLINICAL DRUG DEVELOPMENT BACKGROUND Over 1,200 clinical studies safely and successfully

More information

Katrin Eichelberg, PhD

Katrin Eichelberg, PhD Katrin Eichelberg, PhD Office of Research Training and Special Programs Division of Extramural Activities, NIAID, NIH keichelberg@niaid.nih.gov June 7 th, 2013 Welcome to Bethesda! NIH 27 Institutes and

More information

Graduate Fellowships. Preparing the leaders of tomorrow. school of medicine. The Campaign for Washington University

Graduate Fellowships. Preparing the leaders of tomorrow. school of medicine. The Campaign for Washington University Graduate Fellowships Preparing the leaders of tomorrow school of medicine The Campaign for Washington University Together, we change lives. Washington University educates and trains outstanding scientists

More information

Working in industry. Jon Day BSc(hons), PhD, FSB, CBiol

Working in industry. Jon Day BSc(hons), PhD, FSB, CBiol Working in industry Jon Day BSc(hons), PhD, FSB, CBiol Presentation overview Aims and objectives Who am I? Who are you? Deciding whether to work in industry Transferable skills Career paths Routes of entry

More information

Focus on Your Future: PhD and MD-PhD Programs and Research Careers

Focus on Your Future: PhD and MD-PhD Programs and Research Careers Focus on Your Future: PhD and MD-PhD Programs and Research Careers TWD Program Director s Meeting Chantilly, VA June 4, 2015 Elise Covic, PhD (University of Chicago, Dean of Students MSTP) Sean Crosson,

More information

Statement of the American Pharmacists Association Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA Executive Vice President and CEO.

Statement of the American Pharmacists Association Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA Executive Vice President and CEO. Statement of the American Pharmacists Association Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA Executive Vice President and CEO FDA Public Hearing on Using Innovative Technologies and Other Conditions

More information

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands ETHICS AND THE PSM Bioethics Education in Professional Science Master s Programs at California State University Channel Islands Ching-Hua Wang, M.D., Ph.D., Director of MS Biotechnology and Bioinformatics

More information

Background: Pathways for the Master s Degree (Thesis and Non Thesis)

Background: Pathways for the Master s Degree (Thesis and Non Thesis) Differences between the Non Thesis (Project) and Thesis Options for the M.S. in Pharmacy with an emphasis in BioPharma Regulatory Affairs Offered by the University of Georgia College of Pharmacy Background:

More information

Compensation Resources

Compensation Resources Compensation Resources Compensation is a Philosophy, a Strategy, and a Solution To stay highly competitive you need compensation solutions that help you attract, retain, and reward the caliber of employees

More information

ACRP and APCR 2013 Awards Recognize Excellence in Clinical Research. Association of Clinical Research Professionals (ACRP) Awards:

ACRP and APCR 2013 Awards Recognize Excellence in Clinical Research. Association of Clinical Research Professionals (ACRP) Awards: FOR IMMEDIATE RELEASE: April 15, 2013 CONTACT: Gary Cramer gary@acrpnet.org ACRP and APCR 2013 Awards Recognize Excellence in Clinical Research Orlando, Fla. The Association of Clinical Research Professionals

More information

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from

More information

An integrated global healthcare company

An integrated global healthcare company An integrated global healthcare company 1 A Mission to create healthier communities globally Zydus Cadila is dedicated to life In all its dimensions. Our world is shaped by a passion for innovation, commitment

More information

Saint Francis Care Patient Care Services Advancement to Clinical Excellence Program (ACE Program) INTRODUCTION

Saint Francis Care Patient Care Services Advancement to Clinical Excellence Program (ACE Program) INTRODUCTION INTRODUCTION Advancement to Clinical Excellence (ACE), the Clinical Advancement Program at St. Francis Care was designed to recognize nurses involved in direct patient care and improve promotional opportunities

More information

Sindecuse Health Center Fund 43 Budget Protocol WMU Student Affairs (revised 10-20-2011)

Sindecuse Health Center Fund 43 Budget Protocol WMU Student Affairs (revised 10-20-2011) Sindecuse Health Center Fund 43 Budget Protocol WMU Student Affairs (revised 10-20-2011) Account Structure Department operational accounts and budgets are structured so that the department head (Executive

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

NATURAL MEDICINES TO MANAGE DIABETES

NATURAL MEDICINES TO MANAGE DIABETES NATURAL MEDICINES TO MANAGE DIABETES ACTIVITY DESCRIPTION Some surveys have shown that more than 60 percent of people with diabetes use some type of supplement. There are many supplements which are traditionally

More information

Is it time for a new drug development paradigm?

Is it time for a new drug development paradigm? Is it time for a new drug development paradigm? Robert McDonough, M.D. Senior Director, Clinical Policy Research and Development 1 The Aetna Way Our Cause To make quality health care more affordable and

More information

To learn more about this book, or to place an order, please go to www.cshlpress.com/link/career.htm To view the entire online catalog for Cold Spring

To learn more about this book, or to place an order, please go to www.cshlpress.com/link/career.htm To view the entire online catalog for Cold Spring 2007 by Cold Spring Harbor Laboratory Press 9 Project Management The Product Development Orchestra Conductors Clinical Project Management Product Management Discovery Research Lead Optimization of Drug

More information

UK- India Science Bridge: BioPharm 2020

UK- India Science Bridge: BioPharm 2020 DST INDIA - RESEARCH COUNCILS UK UK- India Science Bridge: BioPharm 2020 Entrepreneurial Opportunities for Indian and UK Scientists in the Pharmaceutical and Biotechnology Industries UK-India Impact Symposium

More information

Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014

Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Oramed Pharmaceuticals, Inc. Initiating Report Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Key data Sector Rating Biotechnology BUY Target Price $45.00

More information

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES SMG 1117.37 FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES DIVISION OF HUMAN RESOURCE SERVICES FOR THE OMPT

More information

Highways and Byways to a Career in Academic General Internal Medicine

Highways and Byways to a Career in Academic General Internal Medicine Highways and Byways to a Career in Academic General Internal Medicine Society of General Internal Medicine 2011 National Meeting Students/Residents/Fellows Program Workshop Faculty Coordinator: Shelly-Ann

More information

A Portrait of the Enterprise Software User in the Pharmaceutical Industry

A Portrait of the Enterprise Software User in the Pharmaceutical Industry A Portrait of the Enterprise Software User in the Pharmaceutical Industry Rahim Kaba - 1/4/2012 4:44:00 PM My article depicting a portrait of the Indian enterprise software user prompted me to develop

More information

Aisling Capital IV, LP

Aisling Capital IV, LP Venture Capital Fund Commitment Aisling Capital IV, LP August 5, 2015 See Last Page for Disclaimer Luke M. Jacobs, Portfolio Manager, Private Markets Overview Aisling Capital IV, LP Venture Capital Fund

More information

Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge

Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge Master of Applied Clinical and Preclinical Research macpr.osu.edu Consortium of Academic Programs

More information

Alternative Practice Options. Upfront Questions

Alternative Practice Options. Upfront Questions Alternative Practice Options Jay Kaplan, MD, FACEP President-elect, American College of Emergency Physicians Practicing Clinician and Director, Patient Experience, CEP America Upfront Questions What do

More information

What do we do at Cimigo?

What do we do at Cimigo? Careers at Cimigo What do we do at Cimigo? As a Market Research Consultancy we help organisations achieve their business objectives: we. Identify opportunities & threats Measure behaviour & attitudes Benchmark

More information

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

Amgen GLOBAL CORPORATE COMPLIANCE POLICY 1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,

More information

Establishing a career in Global Health Research Grant Dorsey, MD, PhD

Establishing a career in Global Health Research Grant Dorsey, MD, PhD Establishing a career in Global Health Research Grant Dorsey, MD, PhD Division of Infectious Diseases San Francisco General Hospital Outline Defining research Choosing a research topic Establishing collaborations

More information

Understanding Enterprise Risk Management. Presented by Dorothy Gjerdrum Arthur J Gallagher

Understanding Enterprise Risk Management. Presented by Dorothy Gjerdrum Arthur J Gallagher Understanding Enterprise Risk Management Presented by Dorothy Gjerdrum Arthur J Gallagher Learning Objectives Understand the components of a wellrun ERM program Review scope and process Explore the role

More information

Principles Governing Advertising in Publications of the American Medical Association

Principles Governing Advertising in Publications of the American Medical Association Principles Governing Advertising in Publications of the American Medical Association Revised December 2012 These principles, developed jointly by editorial and publishing staff, are applied by the American

More information

Canadian Society for Chemistry Membership Handbook

Canadian Society for Chemistry Membership Handbook Canadian Society for Chemistry Membership Handbook Canadian Society for Chemistry Membership Handbook 1 Membership Types and Fees Full Member - $145.00 plus GST or HST Postdoctoral Member - $72.50 plus

More information

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY Key Takeaways from the June 18, 2013 Regional Symposium Nashville, Tennessee THE SYMPOSIUM Trends Shaping the Future

More information

Medical Affairs The Next S-Curve in Pharmaceuticals

Medical Affairs The Next S-Curve in Pharmaceuticals Medical Affairs The Next S-Curve in Pharmaceuticals 2004 Pharma, Biotech and Device Colloquium Michael Conway (michael_conway@mckinsey.com) David Quigley (david_quigley@mckinsey.com) OVERVIEW Medical Affairs

More information

Health System Market Consolidation: Impact on Academic Radiology Departments

Health System Market Consolidation: Impact on Academic Radiology Departments Health System Market Consolidation: Impact on Academic Radiology Departments SCARD 2015 October 16, 2015 Carolyn C. Meltzer, MD, FACR William P. Timmie Professor and Chair of Radiology & Imaging Sciences

More information

The Role of Risk Management in Health Care Provider Mergers and Acquisitions

The Role of Risk Management in Health Care Provider Mergers and Acquisitions The Role of Risk Management in Health Care Provider Mergers and Acquisitions Beecher Carlson - Risk Roundtable Dennis S. Diaz, Esq. Davis Wright Tremaine LLP November 9, 2012 MERGERS AND ACQUISITIONS OVERVIEW

More information

POLICY GUIDANCE & STANDARDS

POLICY GUIDANCE & STANDARDS Current versions of approved documents are maintained online. Printed copies are uncontrolled. Page 1 of 5 POLICY GUIDANCE & STANDARDS TRADING BLACKOUTS FOR RESTRICTED PERSONS Number : CO-059 Date Developed:

More information

Electronic health records: underused in the ICU?

Electronic health records: underused in the ICU? Electronic health records: underused in the ICU? Christopher W. Seymour, MD MSc Assistant Professor of Critical Care Medicine Core Faculty Member, CRISMA Center University of Pittsburgh School of Medicine

More information

Other differences for clinical fellows in non-accredited programs on the NIH campus are illustrated in answers to the questions below.

Other differences for clinical fellows in non-accredited programs on the NIH campus are illustrated in answers to the questions below. Why does the NIH serve as a sponsor to many training programs that are not listed as Accreditation Council for Graduate Medical Education (ACGME)-accredited? Like many other academic medical centers, the

More information

Big Data to Design Quality

Big Data to Design Quality Big Data to Design Quality Practical approach in Pharmaceutical Industry Apr 2013 FORTIER Jean-Etienne KM Specialist VERMYLEN Valérie Director KM RULIER Eric - Senior Project Leader Lab Systems JONE Carl

More information

Questions Employers Often Ask

Questions Employers Often Ask Questions Employers Often Ask 1. Self- evaluation Tell me about yourself. What do I need to know about you that s not on your resume? What s been your biggest challenge in life? What are your greatest

More information

Developing your Portfolio

Developing your Portfolio Developing your Portfolio Considerations for Career Advancement Elizabeth Nelson, MD Associate Dean Undergraduate Medical Education University of Texas at Austin Dell Medical School Alignment of Goals

More information

NATIONAL FEDERAL GRANTS CONFERENCE & WEBCAST ADVANCING HIGHER EDUCATION, SCIENCE & OUTREACH

NATIONAL FEDERAL GRANTS CONFERENCE & WEBCAST ADVANCING HIGHER EDUCATION, SCIENCE & OUTREACH NATIONAL FEDERAL GRANTS CONFERENCE & WEBCAST ADVANCING HIGHER EDUCATION, SCIENCE & OUTREACH OCTOBER 21, 2011 MIAMI, FL Lawrence A. Tabak, DDS, PhD Principal Deputy Director, NaLonal InsLtutes of Health

More information

Clinical Trials and SPA Fall, 2014

Clinical Trials and SPA Fall, 2014 Clinical Trials and SPA Fall, 2014 Laura Williams Frances Spalding Sponsored Projects Administration What to Expect Review of key clinical trial concepts A common clinical trial process How SPA fits in

More information

Conflicts of Interest and the Age of Transparency

Conflicts of Interest and the Age of Transparency Conflicts of Interest and the Age of Transparency Tammy Capretta, RN, MPH, CHC Asst. Vice President, Healthcare Compliance Daniel Shapiro, JD Director, Research Compliance COI-Related Disclosure Requirements

More information

Medical Professionalism in Lebanon: Challenges and Aspirations. Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut

Medical Professionalism in Lebanon: Challenges and Aspirations. Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut Medical Professionalism in Lebanon: Challenges and Aspirations Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut Medical Professionalism in Lebanon: Challenges and Aspirations

More information

A Tech Entrepreneur Meets Academic Pathology

A Tech Entrepreneur Meets Academic Pathology A Tech Entrepreneur Meets Academic Pathology David Nessl, PMP, MBA, Adj. Professor of Business Chief Technology Officer (CTO) Dept. of Pathology / UF PathLabs University of Florida 01/31/2013 A Tech Entrepreneur

More information

B8746: Investing in Medical Technologies Fall 2015 (B-Term); Monday 5:45pm 9:00pm

B8746: Investing in Medical Technologies Fall 2015 (B-Term); Monday 5:45pm 9:00pm B8746: Investing in Medical Technologies Fall 2015 (B-Term); Monday 5:45pm 9:00pm Instructor: Office: Email: TA: Email: Efrem Kamen, Founder & Managing Member, Pura Vida Investments, LLC TBD ejk28@columbia.edu

More information

The agency perspective

The agency perspective The agency perspective 16 January 2014 Anna Palmer Scientific Services Manager Contents What is medical communications? How did I get here? Medical communications vs other agencies What do we actually

More information

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK Medical Science Liaison (MSL): Understanding, Engaging and Interacting Gill Logan Regional Medical Affairs Manager Takeda UK Date of upload, October 2011 Disclosures Takeda UK employee Member of the MSLA

More information

VANDERBILT ASPIRE PROGRAM MODULE COURSE CATALOG FALL 2015

VANDERBILT ASPIRE PROGRAM MODULE COURSE CATALOG FALL 2015 VANDERBILT ASPIRE PROGRAM MODULE COURSE CATALOG FALL 2015 BRET Office of Career Development Vanderbilt University School of Medicine 340 Light Hall medschool.vanderbilt.edu/aspire Overview The ASPIRE Modules

More information

BIH BIOMEDICAL ACADEMY FUNDING OPPORTUNITIES

BIH BIOMEDICAL ACADEMY FUNDING OPPORTUNITIES BIH BIOMEDICAL ACADEMY FUNDING OPPORTUNITIES AT A GLANCE The Berlin Institute of Health (BIH) is a new biomedical research institute focusing on trans lational research. The institute s scientific leitmotiv

More information

Fit Forum V- Successful Innovative Careers. Steven S. Brooks, MD MBA FACC Chief Innovation Officer Sage Growth Partners

Fit Forum V- Successful Innovative Careers. Steven S. Brooks, MD MBA FACC Chief Innovation Officer Sage Growth Partners Fit Forum V- Successful Innovative Careers Steven S. Brooks, MD MBA FACC Chief Innovation Officer Sage Growth Partners Disclosures: None Background University of Pittsburgh School of Medicine 96 Sarnoff

More information

Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD

Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,

More information

Illness knows no boundaries. Fortunately, neither do we.

Illness knows no boundaries. Fortunately, neither do we. Illness knows no boundaries. Fortunately, neither do we. Johns Hopkins Medicine International World-class health care. Global affiliations to share advances. Always focused on the patient. Johns Hopkins

More information

How We Make Sure You Get the Best Health Care

How We Make Sure You Get the Best Health Care How We Make Sure You Get the Best Health Care Table of Contents Quality Improvement... 1 Care Management... 2 Utilization Management: Working to Get You Covered and Necessary Care... 3 Behavioral Health...

More information

Health Care Job Information Sheet #20. Clinical Research

Health Care Job Information Sheet #20. Clinical Research Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour

More information

Biotie Therapies Corp. 4.3.2014

Biotie Therapies Corp. 4.3.2014 1 Biotie Therapies Corp. Corporate Governance Statement 2013 2 CONTENTS 1. Corporate Governance Statement 2. Board of Directors 2.1. Board composition 2.2. The operation of the Board of Directors 2.3.

More information

strategy Therapure Biopharma is open for business P.20 HOW TO CHOOSE INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12

strategy Therapure Biopharma is open for business P.20 HOW TO CHOOSE INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12 INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12 Therapure Biopharma is open for business P.20 HOW TO CHOOSE THE RIGHT outsourcing providers for your oncology clinical trials outsourcing

More information

Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions**

Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions** Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions** Approved by the SOM Committee of Chairs January 23, 2008. Approved by the COP

More information